Stage III-IV or Recurrent Endometrial Cancer
1 clinical trials · Condition
◉ Watch Stage III-IV or Recurrent Endometrial Cancer
| Record | Firm | Date |
|---|---|---|
| Carboplatin-Paclitaxel ± Bevacizumab in Advanced (Stage III-IV) or Recurrent Endometrial Cancer (NCT01770171) | Catholic University of the Sacred Heart | 2012-04-01 |
Track Stage III-IV or Recurrent Endometrial Cancer automatically
Every clearance here is in the API, with alerts when new ones post.